Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | FDPS | P14324 | 3/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.44 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | LAP3 | P28838 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1044719 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL596695 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL5481597 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL27542771 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL27835477 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL27699114 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| Water SCHEMBL27411638 | 0.98 | SMPD1 (0.57) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL8160746 | 0.98 | SMPD1 (0.56) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL4064805 | 0.91 | SMPD1 (0.50) | SMPD1PTPN1S1PR2S1PR1S1PR3 | |
| SCHEMBL3332099 | 0.91 | SMPD1 (0.50) | SMPD1PTPN1S1PR2S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101374805-A | Organic derivatives, their salts and use for the control of phytopathogens | ISAGRO SPA (IT) | 2009-02-25 | — | — | CN | claimed |
| CN-120166902-A | Method for preparing metal oxide material, photoelectric device and electronic equipment comprising metal oxide material | 广东聚华新型显示研究院 | 2025-06-17 | — | — | CN | disclosed |
| US-11439709-B2 | Phospholipid ether analogs as cancer-targeting drug vehicles | CELLECTAR BIOSCIENCES, INC. (US) | 2022-09-13 | — | — | US | disclosed |
| US-9616140-B2 | Fluorescent phospholipid ether compounds, compositions, and methods of use | CELLECTAR BIOSCIENCES, INC. (US) | 2017-04-11 | — | — | US | disclosed |
| WO-2015193669-A1 | DIAGNOSTIC AND THERAPEUTIC METHOD INVOLVING THE AUTOTAXIN-LYSOPHOSPHATIDIC ACID SIGNALLING PATHWAY | BABRAHAM INSTITUTE (GB) | 2015-12-23 | — | — | WO | disclosed |
| EP-2429591-B1 | FLUORESCENT PHOSPHOLIPID ETHER COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | CELLECTAR INC (US) | 2015-08-26 | — | — | EP | disclosed |
| US-20150044142-A1 | FLUORESCENT PHOSPHOLIPID ETHER COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | CELLECTAR, INC. (US) | 2015-02-12 | — | — | US | disclosed |
| US-8871181-B2 | Fluorescent phospholipid ether compounds, compositions, and methods of use | CELLECTAR, INC. (US) | 2014-10-28 | — | — | US | disclosed |
| CN-101374805-B | Organic derivatives, their salts and use for the control of phytopathogens | ISAGRO SPA | 2013-10-16 | — | — | CN | disclosed |
| CN-101909581-B | Sterol-modified amphiphilic lipids | UNIV CALIFORNIA | 2012-11-14 | — | — | CN | disclosed |
| US-20100286510-A1 | USE OF FLUORESCENT PHOSPHOLIPID ETHER COMPOUNDS IN BIOPSIES | CELL ACQUISITION CORP. | 2010-11-11 | — | — | US | disclosed |
| US-20100284931-A1 | FLUORESCENT PHOSPHOLIPID ETHER COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | CELL ACQUISITION CORP. | 2010-11-11 | — | — | US | disclosed |
| US-20100284929-A1 | FLUORESCENT IMAGING OF TUMORS USING PHOSPHOLIPID ETHER COMPOUNDS | CELL ACQUISITION CORP. | 2010-11-11 | — | — | US | disclosed |
| US-20100284930-A1 | FLUORESCENT IMAGING OF SKIN CANCERS USING PHOSPHOLIPID ETHER COMPOUNDS | CELL ACQUISITION CORP. | 2010-11-11 | — | — | US | disclosed |
| US-7811548-B1 | Fluorescent phospholipid ether compounds and compositions | CELLECTAR, INC. (US) | 2010-10-12 | — | — | US | disclosed |
| CN-101374805-A | Organic derivatives, their salts and use for the control of phytopathogens | ISAGRO SPA (IT) | 2009-02-25 | — | — | CN | disclosed |
| CN-1426311-A | Medicament for stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and method for production thereof | MAX PLANCK GES ZUR FUEDERUNG D (DE) | 2003-06-25 | — | — | CN | disclosed |
| US-6506393-B2 | Administering phosphocholine compound; leishmaniasis treatment | ZENTARIS AG (DE) | 2003-01-14 | — | — | US | disclosed |
| US-20010008885-A1 | Methods of treating protozoal diseases | MAX-PLANCK-GESSELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E. V. | 2001-07-19 | — | — | US | disclosed |
| WO-1998024480-A1 | RADIOIODINATED PHOSPHOLIPID ETHER ANALOGS AND METHODS OF USING THE SAME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1998-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150044142-A1 | FLUORESCENT PHOSPHOLIPID ETHER COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | PHOSPHO1, SGMS2, SGMS1 | SMPD1 49/4885PTPN1 3853/4885FDPS 433/4885 |
| US-20010008885-A1 | Methods of treating protozoal diseases | HRH2, HRH1, HRH4 | SMPD1 300/4885PTPN1 4178/4885FDPS 1988/4885 |
| US-20100286510-A1 | USE OF FLUORESCENT PHOSPHOLIPID ETHER COMPOUNDS IN BIOPSIES | PHOSPHO1, SGMS2, SGMS1 | SMPD1 22/4885PTPN1 3279/4885FDPS 439/4885 |
| US-11439709-B2 | Phospholipid ether analogs as cancer-targeting drug vehicles | PHOSPHO1, MCL1, LPCAT3 | SMPD1 44/4885PTPN1 2775/4885FDPS 1622/4885 |
| US-20100284931-A1 | FLUORESCENT PHOSPHOLIPID ETHER COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | PHOSPHO1, SGMS1, SGMS2 | SMPD1 65/4885PTPN1 3879/4885FDPS 426/4885 |
| US-20100284929-A1 | FLUORESCENT IMAGING OF TUMORS USING PHOSPHOLIPID ETHER COMPOUNDS | PHOSPHO1, PEBP1, SGMS1 | SMPD1 67/4885PTPN1 3669/4885FDPS 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.